Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
interferon alpha-2b (Intron-A) (1 trial)
nasvac (1 trial)
nexavar (1 trial)
oncoxin-viusid (1 trial)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis B (Phase 3)
Hepatitis B, Chronic (Phase 3)
Hepatitis, Chronic (Phase 3)
Trials (3 total)
Trial APIs (4 total)